JACKSONVILLE, Fla.—Johnson & Johnson Vision has announced that Peter Menziuso will assume the role of worldwide president, vision care, for Johnson & Johnson Vision immediately. He replaces Swami Raote, who retired at the end of 2020, after a 29-year tenure with Johnson & Johnson. Menziuso comes to the role with over 25 years of experience across Johnson & Johnson, most recently acting as president, cardiovascular & metabolism, Janssen. In his role he led the organization in its mission to advance cardiovascular and metabolic care.

Additionally, Menziuso provided strategic oversight for Xarelto and Invokana in the U.S. as well as the full pharmaceutical portfolio of Janssen products in Puerto Rico and Canada. He was a member of the Janssen Americas leadership team, which guides the pharmaceutical sector strategy for the Americas.

Menziuso is returning to Johnson & Johnson Vision Care, formerly serving as president, North America. Under Peter, North America delivered the highest revenue growth in the last decade and strengthened brand equity for Johnson & Johnson Vision Care's best-selling Acuvue contact lenses in the U.S. and Canada.

“It’s an honor to be back ‘home’ at J&J Vision Care and my priorities remain focused on strengthening our commitment to the eyecare professional community, advancing the trajectory of eye health, and delivering leading innovation to serve the needs of patients around the world,” said Menziuso. “It all starts with our people—creating a strong culture of inclusion and developing highly engaged, diverse teams, while keeping the credo at the forefront in all that we do.”

Menziuso joined Johnson & Johnson in 1992 holding a series of roles of increasing responsibility including regional controller, pharmaceuticals, Asia Pacific; manager of licensing and acquisitions for Janssen Pharmaceuticals; and plant controller for Janssen Ortho LLC in Gurabo, Puerto Rico.